ARBs (Angiotensin Receptor Blockers)
May 10th, 2009
Angiotensin II receptor blockers (ARBs) inhibit the renin-angiotensin-aldosterone system at the level of the Angiotensin II AT1-receptor. ARBs are used to treat high blood pressure, diabetic nephropathy, and congestive heart failure.
No generic ARBs are approved at this time.
In 2010, the patents for Eprosartan, Irbesartan, and Losartan will expire.
| Medication Name | Generic Available | Discount Programs |
| Candesartan (Atacand, Atacand HCT*) | No | The Atacand patent expires in 2012 |
| Eprosartan (Teveten) | No | The Teveten patent expires in 2010 |
| Irbesartan (Avapro, Avalide*) | No | The Avapro patent expires in 2010 |
| Losartan (Cozaar, Hyzaar*) | No | The Cozaar patent expires in 2010 |
| Olmesartan (Benicar, Benicar HCT*) | No | The Benicar patent expires in 2016 |
| Telmisartan (Micardis, Miacardis HCT*) | No | The Micardis patent expires in 2014 |
| Valsartan (Diovan, Diovan HCT*) | No | The Diovan patent expires in 2012 |
*Also contains hydrochlorothiazide
